4214 2.5 (Onglyza saxagliptin 2.5 mg)
Generic Name: saxagliptin
Pill with imprint 4214 2.5 is Yellow, Round and has been identified as Onglyza saxagliptin 2.5 mg. It is supplied by Bristol-Myers Squibb.
Onglyza is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Onglyza saxagliptin 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 4214 2.5
Onglyza
- Generic Name
- saxagliptin
- Imprint
- 4214 2.5
- Strength
- saxagliptin 2.5 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00003-4214 | |
| 00310-6100 | AstraZeneca |
More about Onglyza (saxagliptin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 15 Reviews
- Drug class: dipeptidyl peptidase 4 inhibitors
- FDA Alerts (3)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.